BioScience Managers
As an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare, we have a team with the ambition and experience to deliver impressive investment returns.
Latest news
- Bipartisan bill proposes new ‘pull’ incentives for priority antibiotics 3 July 2018
- AVITA Medical Announces Acquisition of Manufacturing Facility to Support Planned U.S. Launch of RECELL® Device 28 June 2018
- Destiny Pharma notes FDA statement on their focus to enable new approaches to fight AMR 14 June 2018